When Medical Inflation Is Not the Whole Story

When Medical Inflation Is Not the Whole Story

Many health insurers operating in the GCC and MENA markets continue to face growing pressure on portfolio performance. Medical inflation remains elevated, healthcare utilization continues to rise, and provider costs continue to increase.

Yet an interesting question remains.

Why can two insurers operating in the same market, facing similar providers, regulatory environments, and inflationary pressures experience very different portfolio outcomes?

If inflation were the entire explanation, one might expect portfolios to change at roughly the same pace. In practice, that is often not what happens. Some portfolios remain relatively stable, while others experience significant pressure on performance despite pricing actions, underwriting controls, waiting periods, benefit limits, provider management initiatives, and other risk management measures.

Part of the answer may lie in factors beyond inflation alone, including changing healthcare needs, evolving treatment patterns, new technologies, product design, regulatory developments, and behavioural effects.

Among these, behavioural effects are particularly interesting because they can influence both how healthcare coverage is selected and how healthcare services are ultimately consumed.

Behavioural effects are not always adverse. A benefit structure that attracts healthier populations, promotes preventive care, or encourages healthier lifestyles may create favourable selection effects, just as other benefit structures may contribute to anti-selection pressures. Individuals respond to healthcare needs, expected future costs, available coverage, and perceived value. For example, a member may delay a planned procedure until coverage becomes available. A family may place greater value on a particular health plan because of anticipated healthcare requirements. A richer product option may attract a different mix of members than a more basic alternative. Individually, these decisions may appear insignificant. Collectively, they can influence portfolio performance.

These dynamics can be particularly relevant across GCC and MENA markets, where highly mobile expatriate populations, dependent coverage, cross-border healthcare options, and annual renewal cycles can influence both healthcare utilization and the composition of insured populations.

The challenge is that many of these effects can remain hidden within aggregate portfolio statistics.

From Observation to Understanding

Historically, insurers often had limited visibility into the underlying drivers of changes in portfolio performance. While worsening loss ratios and utilization trends could be observed, separating the relative impact of inflation, population shifts, product design, and behavioural effects was often far more challenging.

Today, however, richer healthcare datasets and more sophisticated analytical techniques are allowing insurers to move beyond observing portfolio outcomes and toward understanding the factors driving them.

Rather than viewing portfolio performance as a single number, advanced analytical approaches can help decompose and test the relative influence of inflation, utilization, population shifts, product design, and behavioural effects. Probability-based and stochastic techniques can also help insurers explore questions that traditional portfolio monitoring may struggle to answer.

For example:

• How much of the observed result is attributable to inflation versus changing member behaviour?
• Which products, member segments, or utilization patterns are contributing most to portfolio pressure?
• Is a recent deterioration likely to persist, improve, or worsen?
• What is the probability of future loss ratios exceeding specific management thresholds?

The objective is not simply to produce more statistics. It is to transform portfolio outcomes from observed results into measurable drivers that can support better pricing, underwriting, product design, portfolio management, and strategic decision-making.

For many years, the focus was on measuring outcomes. Today, competitive advantage may increasingly come from understanding the forces that create those outcomes and transforming that understanding into action.

Perhaps the most important question for insurers is no longer:

“What is my loss ratio?”

but:

“Do I understand why it became my loss ratio?”

This article is intended for discussion purposes only and does not constitute actuarial, underwriting, regulatory, accounting, or professional advice.